Dialysis News and Research

Latest Dialysis News and Research

Important issues facing nephrologists to be presented by Satellite Healthcare

Satellite Healthcare, one of the nation's first and leading providers of kidney dialysis services and a major sponsor of nephrology research, today announced that its chief researchers will present at The American Society of Nephrology (ASN) Renal Week 2009.

14 Oct 2009

New Ultra Sensitive facemasks to protect against seasonal and swine flu

BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.

14 Oct 2009

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

Kidney Care Partners - an alliance of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with kidney disease and kidney failure - today applauded the Congressional Black Caucus (CBC) for supporting reforms that will improve patient access and choice in receiving quality kidney care.

13 Oct 2009

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

VitalRemedyMD, a physician-established company, offers scientifically formulated integrative nutritional supplements designed to improve the quality of traditional healthcare. "We are proud that VitalProteinRx is now an integral part of Fresenius' armamentarium in helping patients with chronic kidney disease," stated Dr. Seth Baum, Founder of VitalRemedyMD.

13 Oct 2009

MEDLINE multi-purpose electronic database helps doctors care for their patients

Research funded by The Kidney Foundation of Canada and led by kidney specialists at Lawson Health Research Institute and The University of Western Ontario will make it possible for doctors to quickly and effectively access information relevant for patient care.

12 Oct 2009

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

CANTEL MEDICAL CORP. reported a 65% increase in net income to $4,279,000, or $0.26 per diluted share, on a 4% increase in sales to a record $66,793,000 for the fourth quarter ended July 31, 2009. This compares with net income of $2,596,000, or $0.16 per diluted share, on sales of $64,281,000 for the fourth quarter ended July 31, 2008.

9 Oct 2009

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.

9 Oct 2009

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

As Congress wraps up work on health care reform, members of the American Society of Transplantation's (AST) Public Policy Committee arrived on Capitol Hill today to discuss the importance of supporting a health care provision that would ensure kidney transplant recipients continue to receive.

9 Oct 2009

AST urges Senate Finance Committee to adopt a health care provision for transplant drug extension

As the Senate Finance Committee prepares to vote on the amended health care reform package, members of the American Society of Transplantation (AST) arrived on Capitol Hill armed with a letter encouraging the Senate to adopt a health care provision that will extend Medicare's coverage of post-transplant drugs, which are critical to maintaining the health of the transplant patient. Immunosuppressive drugs are currently covered for a period of 36 months.

9 Oct 2009

Lifeline Vascular Access receives re-accreditation from Joint Commission

Lifeline Vascular AccessSM, the nation’s leading provider of vascular access management services, announced today that it has been re-accredited by the Joint Commission - demonstrating compliance with the Joint Commission’s national standards for health care quality and safety.

8 Oct 2009

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths.

8 Oct 2009

Shire publishes efficacy study results of FOSRENOL and Renagel

Shire plc, the global specialty biopharmaceutical company, today announces the publication in Clinical Nephrology of findings from a head-to-head clinical study comparing the efficacy of two non-calcium based phosphate binders, FOSRENOL(R) (lanthanum carbonate) and sevelamer hydrochloride (Genzyme's Renagel(R)) in chronic kidney disease (CKD) patients on haemodialysis.

7 Oct 2009

Triage NGAL Test allows early identification of AKI in ICU patients

According to a new study now available online, and to be published in an upcoming issue of the Journal of Critical Care, bedside testing for a blood biomarker called neutrophil gelatinase-associated lipocalin (NGAL) in patients being admitted to the intensive care unit can help to identify patients at risk for acute kidney injury (AKI).

6 Oct 2009

Fresenius Medical Care to offer seasonal influenza and H1N1 flu vaccines

As the Centers for Disease Control and Prevention (CDC) predicts a more severe flu season this year, people with chronic health conditions are especially at risk and can develop a more severe illness from any influenza infection, including the H1N1 virus.

6 Oct 2009

Gilbert Hospital to provide renal dialysis services

There is a growing need for renal care, specifically, dialysis and proportionally, that growth is right here in the Valley" said David Wanger, the hospital's chief executive officer.

6 Oct 2009

MHA announces endorsement relationship between AHR, VISTA Staffing Solutions and On Assignment

The Maine Hospital Association (MHA) has announced an exclusive endorsement relationship between their wholly owned entity, Associated Health Resources, Inc. (AHR), VISTA Staffing Solutions, Inc., and On Assignment, Inc.

5 Oct 2009

$APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin$

APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ), and the leading supplier of heparin sodium to the U.S. market, announced today its continued support of the US Food & Drug Administration (FDA) and medical community for the October 1, 2009 implementation of the new United States Pharmacopeia (USP) monograph change for unfractionated heparin.

3 Oct 2009

Data for end-stage kidney disease in the United States available online

Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients at www.usrds.org/qtr/qrt_report_table_new.html.

3 Oct 2009

Research study suggests possibility of safely expanding donor kidney pool by 10 to 15 percent

Kidneys recovered from deceased donors with acute renal failure (ARF) - once deemed unusable for transplant - appear to work just as well as kidneys transplanted from deceased donors who do not develop kidney problems prior to organ donation, according to a new study by researchers at Wake Forest University Baptist Medical Center.

3 Oct 2009

American Kidney Fund to host national gala to support kidney care community

In celebration of people who are living with kidney disease, as well as the individuals and corporations who are working to improve the lives of kidney patients, the American Kidney Fund will host its first national gala, The Hope Affair, at the Newseum on October 6.

3 Oct 2009

Dialysis News and Research

Latest Dialysis News and Research

Important issues facing nephrologists to be presented by Satellite Healthcare

New Ultra Sensitive facemasks to protect against seasonal and swine flu

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

MEDLINE multi-purpose electronic database helps doctors care for their patients

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

AST urges Senate Finance Committee to adopt a health care provision for transplant drug extension

Lifeline Vascular Access receives re-accreditation from Joint Commission

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

Shire publishes efficacy study results of FOSRENOL and Renagel

Triage NGAL Test allows early identification of AKI in ICU patients

Fresenius Medical Care to offer seasonal influenza and H1N1 flu vaccines

Gilbert Hospital to provide renal dialysis services

MHA announces endorsement relationship between AHR, VISTA Staffing Solutions and On Assignment

APP Pharmaceutical continues support of FDA's USP standards for unfractionated heparin

Data for end-stage kidney disease in the United States available online

Research study suggests possibility of safely expanding donor kidney pool by 10 to 15 percent

American Kidney Fund to host national gala to support kidney care community

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Dialysis News and Research

Latest Dialysis News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in